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ABSTRACT 
There are more than 15 million Americans suffering from a chronic cognitive disability 
in the Unites States.  Researchers have been exploring many different quantitative 
measures, such as event related potentials (ERP), electro-encephalogram (EEG), 
Magnetic Encephalogram (MEG) and Brain volumetry to accurately and repeatedly 
diagnose patients suffering from debilitating cognitive disorders. More than a million 
cases have been diagnosed every year, with many of those patients being misdiagnosed as 
a result of inadequate diagnostic and quality control tools.   As a result, the medical 
device industry has been actively developing alternative diagnostic techniques, which 
implement one or more quantitative measures to improve diagnosis. For example, 
Neuronetrix (Louisville, KY) developed COGNISION™ that utilizes both ERP and EEG 
data to diagnose the cognitive ability of patients.  The system has shown to be a powerful 
tool; however, its commercial success would be limited without lack of a fast and 
effective method of testing and validating the product.   Thus, the goal of this study is to 
develop, test and validate a new “Testset” system for accurately and repeatedly validating 
the COGNISION™ Headset.  
A Testset was constructed that is comprised of a software control component 
designed using the Labview G programming language, which runs on a computer 
terminal, a Data Acquisition (DAQ) card and switching board.  The Testset is connected 
to a series of testing fixtures for interfacing with the various components of the Headset.  
The Testset evaluates the Headset at multiple stages of the manufacturing process as a 
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whole system or by its individual components.  At the first stage of production the 
Electrode Strings, amplifier board (Uberyoke), and Headset Control Unit (HCU) are 
tested and operated as individual printed circuit boards (PCBs).  These components are 
again tested as mid-level assemblies and/or at the finished product stage as a complete 
autonomous system with the Testset monitoring the process.  All tests are automated, 
requiring only a few parameters to be defined before a test is initiated by a single button 
press, and then selected test sequences are begun for that particular component or system 
and are completed in a few minutes.  
A total of 2 Testsets were constructed and used to validate 10 Headsets.  An 
automated software system was designed to control the Testset.  The Testset 
demonstrated the ability to validate and test 100% of the individual components and 
completed assembled Headsets.  The Testsets were found to be within 5% of the 
manufacturing specifications.  Subsequently, the Automated Testset developed in this 
study enabled the manufacturer to provide a comprehensive report on the calibration 
parameters of the Headset, which is retained on file for each unit sold. The automated test 
system’s statistical analysis shows that the two Testsets yielded reliable and consistent 
results with each other. 
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I. INTRODUCTION 
A. Background 
 There are more than 15 million Americans suffering from a chronic cognitive 
disability in the Unites States; more than a million diagnosed every year with many of 
those patients being misdiagnosed as a result of inadequate diagnostics. (1-6) A majority 
of the misdiagnoses are due, in part, to the “soft science” or qualitative tools currently 
used for diagnosis, combined with a weak understanding by the medical community and 
device industry of the specific pathophysiologies that cause the disorders.  Specifically, 
until recently, the available methods of diagnosis have included: imaging, psychometric 
testing, and electrophysiology techniques, which have been ineffective and possess low 
efficacy rates for diagnosing common cognitive disorders, especially Alzheimer’s (Luck, 
2005). 
In cognitive disorders, imaging data is still considered to be qualitative since very 
few of the biomarkers available are analyzed computationally.  Rather, images are 
viewed and analyzed by technicians and radiologists that look for specific changes known 
to be associated with a particular disease.  Brain volumetry is a widely used quantitative 
method that calculates changes in volume of different brain structures (Fox, Freeborough, 
& Rossor, 1996).  
Psychometric tests such as the Mini-mental State Exam (MMSE) measure 
memory and cognitive status in patients (Heinik, Solomesh, & Berkman, 2004).  
However, results from these tests can be difficult to discern since a number of these 
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patients also have additional difficulties in communication or movement, such as 
debilitations caused by stroke or other co-morbid conditions.  In addition, conditions such 
as the testing environment where the assessment tool is administered or the number of 
times it has been administered can influence and bias the results as well.   
In the area of cognitive electrophysiology tools, a few medical device companies 
have recently focused their attention on utilizing quantitative measures to improve the 
accuracy, reliability and repeatability of their cognitive diagnostic tools.  For example, 
Neuronetrix (Louisville, KY) has developed a new system, the COGNISION™ Headset, 
which uses the electrophysiological-based parameters of electroencephalograms (EEG) 
and Event Related Potentials (ERP) to diagnose cognitive disorders.  The Neuronetrix 
system has produced promising results in early clinical trials (Fadem, 2008). However, it 
has many functions and features that must be evaluated prior to consumer use.  With the 
lack of availability of an automated platform for validation and verification of this 
cognitive diagnostic tool, quality control and performance evaluation of each Headset has 
been cumbersome and time consuming, which has limited the commercialization of the 
Headset. 
B. Purpose of Study 
The purpose of this project was to develop an automated software platform 
(utilizing the LabVIEW™ graphical programming language) that requires minimal user 
interaction from start-to-finish of the test, but with the capability to accurately, reliably 
and repeatedly validate the performance of each Headset in compliance with FDA 
regulations.  
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C. Hypotheses 
Repeated testing of an individual unit will yield results whose difference between 
trials are not statistically significant. 
Testing an individual Headset unit on two independent Testsets will not yield 
results whose difference is statistically significant. 
D. Significance of Study 
The ability to validate and test medical equipment to ensure valid results is a high 
priority to minimize inaccurate diagnoses and to aid in the quality of care of patients 
suffering from cognitive disorders.  The Testsets produced in this project and the 
automated software that drives them will be used to test a new, promising clinical 
diagnostic tool in a cost effective and time efficient manner. As a result, the performance 
accuracy and reliability of the Headset will improve the quality control of the system and 
contribute towards improving the accurate diagnosis of cognitive disorders.  
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II. LITURATURE REVIEW 
Patients suffering from cognitive decline can become frustrated in not knowing 
the cause, whether it happens slowly as part of the natural aging process or as a rapidly 
accelerated process caused by disease.  Similarly, those born with cognitive disorders, 
typically have the ability to conceive of a normal life and suffer the additional hardship of 
perceiving what the “norm” is for the rest of the population.  To ease the psychological 
pain experienced by these patients, better diagnostic and therapeutic methodologies must 
be developed.  The focus of this chapter will be on identifying the: 1) different types of 
cognitive disorders; 2) current technologies commercially available for diagnosing these 
disorders; and, 3) different techniques implemented for validating and verifying 
performance of the cognitive diagnostic tools. 
A. Cognitive Disorders 
More than 15 million Americans are suffering from a chronic cognitive disability 
in the United States (1-6) and represent a huge cost both in terms of individual 
happiness/comfort and monetary loss to the individual and society as a whole.  These 
conditions range from a life long struggle starting in childhood to debilitating and 
progressive diseases with cognitive decline until death. Some common forms of cognitive 
diseases can be seen in 
.  
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FIGURE 1 : USA Yearly Population Statistics For Common Cognitive Diseases (In Thousands) 
Showing The Prevalence Of The Diseases In The Current Population And The Number Diagnosed Each Year. 
 
The common forms of cognitive disorders in children include attention deficit 
disorder (ADD) or attention deficit hyperactivity disorder (ADHD), Autism, and Down 
syndrome.    ADD/ADHD is a disorder characterized by the patient’s inability to control 
their attention on a subject matter, commonly in conjunction with poor impulse control, 
and seemingly a lack of attention to detail.  Pathology stems from anomalies in dopamine 
pathways related to the “reward center of the brain.” According to epidemiological data, 
approximately 4% to 6% of the U.S. population has ADHD (Jaska, 1998). 
Down syndrome is caused by a genetic defect and the syndrome is generally 
apparent from birth.  It has an easily distinguished phenotype and can cause significant 
mental retardation.  Unlike many of the other diseases, methods of diagnosis are not the 
primary concern for Down syndrome; current research is pursuant of quantitative 
cognitive measurements to improve the understanding of drug efficacy. (Cano et al., 
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2010)  Measurements related to cognitive performance are taken before and after 
administration of drugs that hold promise for improvement of the deficits associated with 
Down syndrome. 
Autism is a developmental disorder that appears in the first 3 years of life, and 
affects the brain's normal development of social and communication skills.  The severity 
of the disorder can impede the ability for education and cognitive assessment.  Like 
Down syndrome, there is a great need for the ability to quantify the cognitive function of 
the affected patients (“Alzheimer’s Disease  Facts and Figures,” 2010).  
Chronic cognitive disabilities have been occurring in adult patients at an 
expanding rate from factors such as the increase in life expectancy and improved health 
care from the mid 70’s to present, which has lead to an exponential increase in 
cognitively impaired adults.  The number of age-related cognitive deficient adults will 
probably continue to increase until 2050 as a result of the aging baby boomers population 
and increasing life expectancies; at that time, more than 1 out of 5 people will be over the 
age of 65 (Obeso et al., 2008).  In the aged population, cognitive disabilities are caused 
by the onset of cognitive diseases, such as Alzheimer’s, Parkinson’s or part of the natural 
aging process.  
Alzheimer’s disease is characterized by slow brain cell death from beta amyloid 
plaque burden and tau.   The first outward signs of the disease are forgetfulness which 
makes memory and cognitive function the current target for early detection (Obeso et al., 
2008).  Parkinson’s disease consists of the death of mid-brain dopanergic secreting 
neurons, resulting in lower amounts of dopamine reaching their target receptors; thereby, 
causing a decline in the individual’s ability to control voluntary muscles (Michael J. Fox 
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Foundation, 2012).  Research is ongoing in determining why the later stages of the 
disease exhibits cognitive decline (National Institute of Neurological Disorders and & 
Stroke, 2004)(Schizophrenia.com, 2010). 
Schizophrenia – disease characterized by paranoia, delusions, hallucinations and a 
detachment from reality (Robi Polikar et al., 2008).  A lifelong disease usually starting 
between the ages 18 and 30, it manifests from mild to acute, and can distort memory and 
normal cognitive behavior.  This disease’s prevalence is roughly 1 in 100 adults. (Robi 
Polikar et al., 2008) Cognitive Diagnostic Modalities 
With the increasing number of people being affected by these diseases, it is 
becoming of critical importance that accurate diagnostic techniques be implemented.  
However, the majority of diagnostic methods currently used are based on “soft science” 
or more qualitative approaches.  As a result, in the case of Alzheimer’s for example, there 
is a low efficacy percentage of diagnosis, about 75 % (R. Polikar, Greer, Udpa, & 
Keinert, 1997).  Thus, many patients are diagnosed as either false positive or false 
negative with the disease. Subsequently, many patients receive, or do not receive, the 
appropriate treatment for their disease case. Lack of early detection or proper diagnosis 
often times results in an unnecessary cognitive decline in the patient before effective 
treatment can be applied. 
Currently, there are a variety of modalities that have been used for diagnosing and 
assessing the cognitive and physiological state of the brain.  The primary diagnostic 
modalities include: 1) imaging methods, which give an excellent spatial understanding of 
disease pathology and clearly show morphological changes; 2) cognitive assessment 
methods involve questionnaires and quizzes to stress the various cognitive functions and 
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elicit standard responses; and, 3) electrophysiological methods, which provides great 
temporal resolution, but poor spatial resolution.  Great temporal resolution (Casey, 2011) 
s to changes that are observable on the order of milliseconds, where as poor spatial 
resolution (Millet, n.d.) s to difficulties in determining where exactly in the brain the 
signal originates. Research has been done for each type of modality (described below) 
along with the development of specific biomarkers that correlate with the disease(s) in 
question. 
B. Imaging Methods 
Imaging methods such as Computer Tomography (CT), Magnetic Resonance 
Imaging (MRI), and Positron Emission Tomography (PET) are able to show the physical 
changes that occur with disease. CT is used to generate anatomical images of the body.  It 
does this by passing a body through a donut shaped machine, an x-ray emitter and 
collector then whirl around the inner circumference of the ring at high speed and collect 
information as the body is passed through the center.  The computer reconstructs the 
image as coronal slices, which can then be rendered into three dimensional images of the 
body.  Similarly, MRI also focuses on anatomical features; however, the mode of 
operation is different.  MRI uses a power magnetic field and electromagnetic pulses at the 
resonance frequency for hydrogen nuclei.  Once affected some of the nuclei will release 
their own photons at the varying densities depending on their concentration in the tissue, 
i.e. the water concentration of the tissue. The reconstruction is the same as for MRI 
images once the signal has been collected.  Separately, the primary purpose of PET 
imaging is to determine the physiological functionality and activity of specific regions of 
the body under investigation.  PET relies on radioisotopic decay of an injected or 
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ingested material.  As the isotope decays it releases the radioactive particles and they are 
collected by a scintalator much the same as the MRI and CT collect their signals.  Just 
like the MRI or the CT, the images are reconstructed from the signal. 
Both MRI and CT can detect certain cognitive diseases via brain volumetry and 
they both have comparatively high spatial resolution as opposed to other imaging 
methods. In brain volumetry, the brain is imaged, a 3D model is constructed and voxels 
(3D equivalent of pixels) are used to gauge the volume of specific brain structures under 
investigation (Zakzanis, Graham, & Campbell, 2003).   In Alzheimer’s disease, for 
instance, there is a significant decrease in volume of all brain structures over time, 
particularly the hippocampus early on (Hostetler et al., 2011). However, while there is a 
positive correlation between brain volume and certain diseases, the likelihood of a false 
positive is significant since many perfectly normal, healthy geriatric patients also have 
brain shrinkage and do not exhibit cognitive decline (Fox et al., 1996).   
Meanwhile, PET imaging has a fairly low spatial resolution in comparison to MRI and 
CT, but has made progress in positively identifying persons with a beta-amyloid plaque 
burden (Drzezga et al., 2008)(Wind et al., 1997).  This method also has a tendency to 
yield false positives, since all persons with Alzheimer’s have a substantially higher than 
average amount of beta-amyloid plaque accumulation.  However, not all persons with 
beta-amyloid plaque accumulation have dementia. With all the types of imaging 
techniques implemented thus far, disease detection is limited in the pre-dementia and 
mild impairment phase, since insufficient damage has occurred to be identified in the 
images. 
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C. Psychometric Methods 
The psychometric tests fare better than the imaging techniques listed above at 
assessing cognitive function, but have a number of drawbacks. There are many of these 
tests and some physicians use them as a routine diagnostics, however, each test targets 
and analyzes very specific pathways of the brain to ascertain if those sections of the brain 
are working correctly.  There are hundreds of published psychometric tools, but for 
evaluating memory the MMSE has been adopted by many physicians as well as being 
incorporated into the Alzheimer’s disease Neuro-imaging Initiative (ADNI) protocols for 
diagnosing Alzheimer’s (Casey, 2011). Although these tests have been developed to do 
their best at eliminating exogenous variables; they are affected by the test giver’s 
demeanor, patient alertness, patient disposition, and outside distractions.  A test subject 
may have highly variable test scores from one week to the next, making disease 
correlation difficult from these various factors.  Also, cognitive tests of this nature cannot 
be repeated frequently as the subject “learns” the test, so their performance will improve 
from practice or decrease from boredom as a function of frequency and total number of 
tests given, giving unpredictable results (Steinmetz, n.d.)  
 
FIGURE 2 : View Of Four ERP Epochs From Three Channels.  Each Epoch Is A Stimulus Response EEG 
About One Second Long.  The Blackvertical Bar Represents When The Stimulus Occurred.  
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D. Electrophysiology Methods  
Another method for evaluating cognitive ability is electrophysiological testing. 
There are several types of electrophysiological signals which have been used to date to 
evaluate cognitive ability including, magnetic encephalograms (MEG), 
electroencephalograms (EEG) and event related potentials (ERP).  An EEG is performed 
by placing electrodes on the scalp and monitoring the brain waves produced by the test 
subject (FIGURE 2)  The waves emanate from the changing of the average polarity of a 
region due to neuronal activity. With help from low impedance amplification, the 
microvoltages collected at the scalp can be amplified to voltages capable of being 
digitized and recorded by a computer.  The MEG techniques can be utilized the same way 
as the EEG techniques, however the cost of building the collection arrays are magnitudes 
more expensive. MEG detectors are as large as MRI and CT scans, making them 
unportable. MEG works by picking up the magnetic field changes, these signals are 
attenuated a great deal more by distance than EEG, but are less distorted by the skull, and 
therefore provide better spatial resolution than that of EEG. 
ERPs are created by repeatedly subjecting the test subject to a stimulus: light 
pulses, images, sounds, vibrations, etc., and then collecting the time locked brain waves 
that follow (either EEG or MEG). Time locked signals refer to the coordination of the 
signals in relationship to each other and the high precision system clock that keeps track 
of when the signal was produced.  These time locked signals are then overlaid upon one 
another and averaged for each sample time starting with the time of the initial stimulus. 
Any brain waves not related to the event related stimulus will average to zero (FIGURE 
3), leaving only the signals associated with the patient’s response to the stimulus (Luck, 
2005).  These signals have unique characteristics depending on the stimulus paradigm 
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which can be analyzed to yield probabilities for different diseases using a trained 
classifier to examine wavelets, latency, amplitude, polarity and other features (R. Polikar 
et al., 1997). 
 
 
FIGURE 3 : Single Data Channel Showing 100 Overlaid ERP Epochs (Blue-Green) And The Average Of The 
Epochs (Red).  The Peaks At 200 And 300 Ms Are Tell Tale Peaks Used In Alzheimer’s Detection. 
 
The benefit of using ERP over other forms of cognitive assessment is that it 
allows monitoring of the precognitive and cognitive responses to stimuli.  When a 
stimulus is imposed, there are brain waves generated by other areas of the brain leading 
up to the moment when the cerebral cortex (the part of the brain responsible for cognitive 
comprehension) receives the information.  The significance of precognitive activity is 
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that the patient cannot influence the results of the stimulus; making it an additional 
independent measure of brain activity unaffected by the subject’s thought processes.  The 
brain wave’s features associated with these diseases are unique; thus, a powerful 
computer in conjunction with a trained classifier and quantitative analysis method can 
yield reliable pass/fail results when testing for a specific disease. 
Unfortunately, unlike the panacea of cognitive assessments and brain imaging 
modalities, electrophysiology methods have not been as widely accepted as a tool for 
clinical diagnosis as other modalities other than for sleep and seizure studies.  Their use 
in determining cognitive disorders is rare in a clinical environment due to the lack of 
dedicated ERP systems and problems, thus far, with comparable results from lab-to-lab 
and the need for specially shielded rooms. EEG setups have been traditionally 
customized by individual labs using software and custom stimuli to record the ERPs.  As 
a consequence of this, it has been difficult to compare data from one lab to another as no 
two labs had the same equipment, or the same test paradigm.  Unlike imaging modalities, 
which simply take a picture of an existing structure, ERPs actually evoke, via a specific 
stimulus, a distinctive response.  Unless the stimulus is the same from one test to the 
next, and one lab to another, the response will not be comparable, so a common 
designated biomarker cannot be easily identified. 
E. Neuronetrix COGNISIONTM System 
Recently, a dedicated ERP system has been developed, COGNISIONTM 
(Neuronetrix, Louisville, KY), and is currently being evaluated in clinical trials.  The 
COGNISIONTM Headset (hereafter referred to as Headset) allows ERPs to be collected in 
clinical settings with a high level of accuracy and little variation from laboratory to 
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laboratory or between devices (Swaminathan, Mohan, & Arunachalam, n.d.).  The 
Cognision Headset is a handheld, wireless, ambulatory, ERP device for the diagnostic of 
cognitive disorders.  It is designed specifically to perform ERP tests and their ability to 
produce biomarkers associated with cognitive disorders.  
F. Validation and Testing 
As with any medical device, ensuring a device is robust, safe and effective is of 
paramount importance and is achieved through the implementation of proper validation 
and testing procedures.  The consequences of releasing an un-validated device into the 
market can be dangerous, even fatal, in instances where electrical shock is possible, e.g. 
open brain or heart surgery, and subcutaneous catheterizations (Reid, 1978). The FDA 
requires that medical devices be tested and validated to ensure they are safe and effective 
to gain approval for clinical use and sale [CFR21 Part 11 and Part 820](22). The FDA 
does not provide a strict requirement about how the validation and verification processes 
are performed, so the scope of methods implemented by companies vary from the simple 
use of statistical methods, where only a small percentage of devices are tested, to the use 
of robust, fully-automated techniques developed by the respective, individual company.   
Currently, laboratories evaluate EEG and ERP systems via a manual process 
using individual pieces of electronic testing equipment such as oscilloscopes, function 
generators, and custom built hardware.  Measuring parameters as simple as frequency 
response or gain linearity can take an hour each. Some test systems exist, such as the 
FLUKE Medtester series, which is primarily a Biosignal generator used to test EKG 
devices;  however, these testers are limited because they lack the ability to test equipment 
with complex functions and built in firmware, such as those found in ERP devices.   
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III. INSTRUMENTATION AND EQUIPMENT 
A. Cognision 3000 Headset 
The COGNISION™ System (CS) consists of a ten-electrode headset and control 
unit (Figure 4a) with signal conditioning (Figure 4b) to measure EEG and ERP for non-
invasive, early-stage detection and diagnosis of clinically-significant neurological 
disorders.  The CS concept leverages clinically-accepted diagnostic ERP technology to 
record the electrical activity of a patient’s brain waves (typically 100 µV pk-pk) while the 
brain is stimulated to perform cognitive tasks that are specific to the cognitive disease 
being tested.  
 
FIGURE 4 : The COGNISION™ 3000 Consists Of (A)  Ten-Electrode Headset, (B) Control Unit, And (C) Data 
Acquisition. The Uberyoke (1. White Box) Contains Electronics For Signal Amplification, Analog-To-Digital 
(A/D) Conversion, And Control Logic (C). 
Advanced signal processing techniques are applied to these data to elucidate the possible 
disease state(s).  Pattern recognition software is used to identify disease specific 
biomarkers associated with specific regions of the brain that are linked to cognitive 
performance.  The trained cognitive classifier assesses the probability of a disease by 
comparing morphological features of the patient’s recorded brainwave activity during 
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cognitive testing to a database of brain waveforms with characteristic features associated 
with a variety of cognitive disorders.  
The CS offers many technological advantages and clinical benefits compared to 
other commercially-available ERP devices.  First, current ERP devices are large in size 
and weight requiring transport within the hospital environment on carts.  In contrast, the 
CS is a portable, light-weight, handheld device.  By leveraging electronic miniaturization 
and advances in cell phone technology, a personal computer (PC) and data acquisition 
system have been replaced by a unit that fits in the palm of the hand. 
 
FIGURE 5 : XLTEK Design, Notice The That It Requires A Cart To Mobilize The Equipment (Left). 
COGNISION™ The Small Size Makes It Far More Portable (Right). 
 
These improvements enable clinicians to use the CS in remote setting(s), which 
were previously inaccessible (i.e. sports arenas, battle fields, and EMS ambulatory units).  
Second, the CS is wireless allowing for untethered communication, and data transfer, 
allowing physicians and support staff to monitor test subjects from a separate room 
without disturbing them.  The CS uses active electrodes for EEG measurements, which 
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can be used in conjunction with integrated circuits (IC) to perform specialized tasks.  For 
example, real-time impedance verification is used to continuously monitor and validate 
that the active electrode maintains a low impedance electrical contact with the patient.  
Current ERP devices employ ‘passive electrodes’, electrodes that do not contain any 
electronics, the electrodes can often become disconnected during cognitive testing 
without any indication and that can result in aberrant or corrupt data.   Additionally, the 
CS signal conditioner is designed with unity gain (signal buffering) to minimize signal 
degradation between the electrode and the amplifier for better signal-to-noise ratio 
(SNR). The CS Headset continually samples electrode impedance, monitors for artifacts, 
and ensures all cognitive test sequences are completed and sample data recorded. 
 
FIGURE 6:  Hydrodots Seen From Various Angles.  The AG/AGCL Tabs Of Each Hydrodot 
Articulate With A Metal Contact Ring In Each Electrode Pod.  The Gel End Of The Dot Articulates With The 
Patient Scalp. 
Hydrodot™ electrode contacts are used for maintaining electrical continuity 
between the sensing electrode and patient.  The current clinical practice involves the use 
of a blunted needle to abrade the patient’s scalp (preparation) and apply saline or 
electrolytic gel (coupling) to acquire the voltage potential at the electrode placement site.  
This procedure can be uncomfortable, sometimes painful, and messy.  In contrast, 
Hydrodots™ (Figure 6) are a gelatin electrolytic pod that maintains its shape, and 
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provides superior physical contact and silver/silver chloride contact electrical coupling to 
acquire higher-fidelity EEG waveforms. These special features and unique electrodes 
make the system more complex for testing than other EEG/ERP test systems, and require 
a sophisticated tester to ensure the highest quality products. 
 
 
FIGURE 7 : CS Testset, On The Left The (A.) MSBB And (B.) Testhead, The Right Side Of The Image 
The (C.) Testboard Which Is Currently Populated With A CS 3000 System Ready For Testing. 
B. COGNISION™ Testsest 
The physical Testset is a proprietary hardware device for testing the Headset.  The 
complete Testset (hardware and software) is an automated test fixture with the ability to 
test the Headset at each stage of Validation and Verification testing during the 
manufacturing process.  The Testset includes a software control component designed on 
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the National Instruments LabVIEW platform using the LabVIEW G programming 
language, which runs on a computer terminal and a Data Acquisition (DAQ) card + 
switching board. The “Magical Switching Bio-signal Board” or MSBB (as termed by 
Neuronetrix) connects to a series of test fixtures for interfacing with the various 
components of the Headset.   
The Testset can simulate the Headset HCU to test entire system(s) or individual 
component(s).  There are 14 separate configurations (see appendix c, section 7) that allow 
trained technicians to test each component against a known test standard, or use the 
component independently with the Testset to simulate the entire CS 3000 system. For 
example, an Uberyoke can be placed on the Testboard with a set of “golden” strings 
(term indicating calibrated and validated electrode strings used as standard) and the 
Uberyoke’s circuitry tested by subjecting it to analog tests and executing its firmware 
commands to control its digital switches.  Analog tests such as: power consumption, 
baseline noise, Cal tones test (calibration tones used for measuring impedance while an 
ERP test is in progress), frequency response, gain linearity, and cross talk can be 
performed via the custom software interface. 
The Testset allows a variety of test to be performed in an automated fashion.   
There are noise level tests, noise sources from both internal components of the Headset 
and from electrical magnetic interference (EMI), and baseline noise values external to 
electrodes.  The frequency response, common mode rejection ratio (CMRR), cross-talk, 
and gain linearity are all tests that are incorporated into the single automated test suite; 
allowing the press of a single button to pass or fail individual pieces of equipment or 
entire Headsets. 
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1. DAQ Card Control   
The (Data Acquisition) DAQ card (Ue9 Labjack, Denver, Colorado) (FIGURE 8) has 
many features and functions for collecting and generating signals. Universal 
asynchronous receive/transmitter (UART), serial port interface (SPI), Streaming DAC 
out, streaming analog signals in from the Kelvin circuits (current monitoring), and Digital 
Input/output for switches that are distributed throughout the MSBB (magical switching 
Biosignal board. The DAQ card is the single most important piece of hardware as it 
serves as the interface between all the various switches and parts in the Testset, and the 
computer.  This data card needed to have communication channels for SPI and UART, 
(industry standardized communication protocols that exist in the Uberyoke and HCU).  It 
also required analog inputs and outputs, for simulating waveforms and monitoring the 
voltage output of the current monitors.  The digital I/O (DIO), although not enough to 
drive all the switches on the board, was required to drive the port expanders.   
FIGURE 8 : Labjack Ue9, the DAQ card and “brains” of the testset.  It functions as the 
interface and programmable circuitry that drives all the switches in the Testset. 
The Labjack is the brains of the Testset; it is the controller for all of the switches 
in the MSBB.  The DAQ card serves as the interface between the computer and the rest 
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of the hardware.  It generates the Biosignal, has the firmware necessary for interpreting 
the information sent from the computer to control switches, and communicate with the 
various chips and peripherals.   
2. Port Expanders 
 (MCP23S08, Microchip Technology INC., Chandler, Arizona) The DAQ (Data 
Acquisition) card did not possess enough Digital I/O ports (DIO), requiring a port 
expander chip to be used.  These port expanders give a system an expanded ability to 
control a greater number of digital switches. This is necessary because there are not 
enough ports on the DAQ card to control the MSBB.  (For a comprehensive list of 
switching needs, see PS-1487, section 7.4). Several of these chips were used to provide 
the necessary switching capacity in the MSBB.  There were a total of 12 additional DIO 
added with the use of the port expanders.  
The chip uses a 4 wire communication protocol called SPI (Serial Peripheral 
Interface).  The DAQ card had driver level function calls for operating 4 of the digital 
channels (DIO0 - DIO3) as SPI lines.  The port expander was prototyped on bread boards 
and controlled with the DAQ card.   In using the chips the first step after wiring them 
correctly is to initialize the registers.  The initialization procedure defined by the 
manufacturer in the chip specification did not work according to specification. The 
specification for the communication protocol for the SPI did not mention how to properly 
initialize the chip, the first register had to be written twice, to be responsive.  Several 
additional registers were required to be set for the chip to perform for this application.  
The registers are responsible for port direction (R/W), Port polarity (inverted/normal), 
port state (high/low) and whether the chips responded to all commands or only 
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commands that are specifically addressed to them with a two bit code. The addressing 
register was set last, since it resulted in the initialization needing only to be sent globally 
instead of addressing each chip individually; resulting in a 75% reduction in the amount 
of time necessary to initialize them.    The DAQ card’s SPI channels only output 3.3 
volts, but the operating voltage for the port expander is 5V. As a result, a level shifter 
(Schmitt trigger) was required to shift from 3.3 to 4.5 volts.   
3. Kelvin Circuits  
Kelvin circuits infer the current draw of a particular component by comparing the 
voltage at two different points along the VS for a particular component.  They make it 
possible to determine if a short or an open is occurring when a component is placed on 
the Testboard.  Uberyokes, HCUs, and electrode strings all have a known nominal current 
draw and deviations from these numbers are flagged for investigation.  These are sampled 
with the Testset’s analog inputs and a switch in the Labview application was designed to 
enable sampling of those ports and report them in a graph. 
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C. Testhead 
The test head is a fixture for testing the device as a finished assembly.  The 
Headset is mounted on the Test Head with an emitter post for each electrode and signals 
are then fed to the electrode posts.  The Test Head is a modified Styrofoam display head 
for selling wigs and hats.   It has ten electrode post made from sections of brass pipe, 
each pipe has a flexible rubber column with a screw inserted through it and a copper 
braid attached.  The copper braid serves as a flexible conductor for making contact with 
the Monel ring of the electrodes. Once the Headset is in place, the screw is tightened and 
the rubber tube, bulges out, causing the copper braid to articulate with the Monel ring of 
the electrode. 
FIGURE 9 : Testhead, A Fixture Of The Testset Wearing The COGNISION Headset.  This Fixture Is 
Used To Test The Headset Once It Is Assembled And Completed Systems.  It Allows The Simulated Biosignal To 
Be Injected Into The Electrodes With Conductive Post That Articulate With The Electrode Pod’s Monel Ring. 
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D. Testboard 
 A test fixture, this is the actual interface between the hardware to be tested and 
the hardware of the Testset. The Testboard functions as the distribution highway for all 
the signals of the MSBB and Headset.   It has only a minimal amount of active circuitry 
on it, with the idea that any changes to the Headset or degradation of the Testset will 
occur with the Testboard; it can be easily redesigned, and repaired.  When designing the 
Testboard the major consideration was EMI.  The signals output to the Headset are in 
microvolts and these signals have to be shielded with ground planes and spatially isolated 
to prevent noise from entering the conductors.   
FIGUER 10 : Test Board With 1.HCU TOP, 2.HCU BOTTOM, 3.Uberyoke, And 4.Electrode Strings 
In Position.  This Is A PCA Test Fixture That Allows The Unassembled Components Of The CS System To Be 
Mounted And Tested. 
The baseline noise of this system is as low as 500 nano-volts.  The Bluetooth 
emitter on the HCU had to be placed as far from non-digital signals as possible to prevent 
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interference.  The only circuits that are located on the Testboard are solid state switches, 
and the Kelvin circuits.   
E. Oscilloscope 
 A Tektronix oscilloscope with 100 MHZ bandwidth and 1 GS/s sample rate, 
it has standard features, 12 automated measurements, and context-sensitive help (Figure 
11).  The various features allow signals to be monitored as it progresses through the 
Testset, and to determine the appropriate voltages of the inputs and outputs.  The o-scope 
was used during prototyping and to validate the test set. See Appendix B PS-1487 section 
7 on validation for more information. 
 
FIGURE 11 : Tektronix Multifunction Oscilloscope.  This Was The Principle Tool For Validating The 
Testset As Well As Testing Its Circuits During Research And Development. 
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F. Function Generator 
 A Function generator (BK Precision) with variable DC offset, 4 digit LED 
display, course and fine tuning; it can produce sine, square, triangle, pulse, and ramp 
outputs (FIGURE 12).  It’s range is 0.2 Hz to 5 MHz in 7 ranges. This piece of 
equipment was primarily used to validate the Testset’s signal input and output.  See 
Appendix B PS-1487 section 7 on validation for more information. 
FIGURE 12 : BK Precision Function Generator, Used To Produce A High Fidelity Signal And Validate 
The Signal Generator In The Testset 
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IV. PROCEDURES 
A. Device Design 
User Needs – A list of test were generated by itemizing the subsystems.  A test 
was created for each subsystem.  A basic consideration that helped to generate the 
specification was how to accomplish the tests that needed to be performed. (For a 
complete detailed list of design specifications see Appendix B section 7 PN-1487 section 
7 SPECIFICATIONS) Prototyping (see PS-1487 Section 5 Block Diagram for hardware 
flowchart) 
B. LabVIEW Application 
(LABVIEW 11.0, National Instruments, Austin, Texas) Developing a (LabVIEW 
Virtual Instrument) VI for access to the virtual serial port with the Bluetooth Technology 
was necessary to test communication with the HCU.  A Bluetooth Development Board 
(BDB) by Ezurio (Model number omitted) was utilized as a learning tool for 
communicating and interacting with the Bluetooth interface.  LabVIEW currently does 
not have a function or module for pairing with Bluetooth devices.  Instead, a third party 
library, 32feet-in-the-hand, which is an open source technology that allows pairing with a 
Bluetooth device.  After pairing with the device a virtual com port was allocated to 
enable serial communication with the device.  Once the Bluetooth device was paired and 
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a port set up, a standard serial communication protocol was all that was required for 
communication with the device via ASCII or hex commands.    
C. Labjack UE9 DAQ Card 
The first step to controlling the Testset was to learn how to communicate with the 
UE9; it has an USB connector and an Ethernet connector.  It was established that the 
Ethernet communication would allow for more flexibility in control, as the Testset could 
then be controlled from anywhere and to anywhere provided there was network access.  
Low level VI functions were designed to access each port both digital and analog, and 
communication protocols such as SPI and UART. 
D. MSBB (Magical Switching Biosignal Board) 
This board interfaces between the Labjack and the Testboard.  It contains all the switches, 
and signal conditioning elements necessary for testing the board with the exception of the 
components that have restrictions on the length of their conductors,  i.e. CCS –ICDU64 
programmer and the Kelvin circuits.   The ports on the Labjack and interfaces can be 
used to turn the switches on and off to redirect signals and talk to the chips.  After the 
basic input output functions were finished, sub routines were made to control the 
switches, such as initialization, and state machines. 
E. Test Design  
(See section 9 of PS-1487 of Appendix B) 
The tests were designed with a common template in mind:  Initialize Testset -> 
Get User input-> Perform Test -> Test data for Pass/Fail -> Generate report.  The 
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Graphical User Interface (GUI) also had a template design, with the user controls on the 
left and the indicators on the right; with common controls and indicators between tests.  
A common theme for button colors, shapes and sizes were also used (Example 
screenshots of the GUIs can be seen in PS-1487, section 9).  Error monitoring and stop 
buttons were incorporated into each tests, the testset hardware was designed to prevent 
any states from causing damage, but having a stop button to terminate the execution of a 
test saves time in the instance that a test needs to be reset. 
Each test had a unique task to accomplish, using a common test pattern. Each test 
required data collection for some number of samples, and with some parameters.  Either a 
single one shot data collection (single sample set) or a loop that varied a parameter such 
as frequency or gain.  The Frequency Response Test and Common Mode Rejection Ratio 
(CMRR) test both required a loop to run that varied the frequency and kept the amplitude 
constant, because of this both test were incorporated into the same panel, a single switch 
in the MSBB  would short all the inputs to each other for the common mode.  The Gain 
Linearity Test required constant frequency with varied amplitude.  The same loop 
structure could be used for all three tests with a different formula for each loop structure 
that regulated frequency, amplitude, and number of samples.  The crosstalk-noise test 
only differed in that in the crosstalk test there was a signal being injected to one electrode 
at a time.  For this test, the loop process is nested inside a of a larger loop that controls 
the channel that is open.  For a full description of each test see Paragraph (0 of section 
0IV Procedures. 
Tests required pass fail parameters to determine the pass/fail criteria for the 
received signal amplitudes and frequencies.  The method used to measure was identified 
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and implemented.  Tests required built in LabVIEW tools for detecting frequency, 
amplitude, peaks, and rms.  The criteria can be seen in the example test system report of 
Appendix-B. 
F. Validation of the system 
1. Data Validation  
The Testset and tests were validated systematically and incrementally.  The first 
steps were to validate the Testset to make sure all the individual components were 
performing as expected.  As an example, when a signal was set in the application to 400 
µV, a voltage of 2.5V is expected to be at input of the voltage dividers (See PS-1487 
section 7, Appendix B for example values). Several test points were added during the 
design phase, all with expected values to help validate the system.  Voltages and 
frequencies at each test point were tested, to ensure that the values match expectation.  As 
an example:  The output of the DAQ card was 0 to 5V which was ultimately divided to a 
dynamic range of -400 to 400 mV, with a resolution of 12 bits, a sensitivity of 97 nV.  
Then when the tests were performed, the same procedure was repeated, this time probing 
the test points monitoring the changes in the values as the test progressed.  Other test 
points allowed the observation of digital signals.  Visual inspection of the signals were 
used to make sure that there was not excessive slew (that the signals contained square 
waves) and that they were the proper voltage (3.3V, 5V, or 6.3V).  
2. Pass/Fail Tolerances 
The Neuronetrix Headset engineers provided the values for the tolerances, but the 
method is explained: The circuits all had theoretical values for their outputs and 
deviations from those values.  The resistors and capacitors all had 1% or 5% tolerances 
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and based on the arrangement of those chips, the tolerances were either constant or 
additive.  Some of the tolerance levels were specifically calculated using tolerances of 
parts and specifications, such as noise levels and CMRR.  Other tests’ tolerance levels 
were calculated but the band which the values fell in where determined experimentally; 
such as in the frequency response test.  
 There were several tests designed to validate each Headset.  See PS-1487 
section 9 for a full description and instructions for use of each test.  These tests were 
integral to ensuring robust, high quality diagnostic devices in the field. The tests are: 
• Current Draw 
• Noise Test 
• Cal Tones Test 
• Frequency Response 
• Common Mode Rejection Ratio 
• Gain linearity 
• HCU Function Testing 
• Generated Results  
Results were generated by a common subVI which included relevant information 
in the header about the device and test being performed, followed by the test data 
interpretation.  (see PS-1487 section 13 for a copy of Volume Record (VR) 1524. 
3. Test Procedure General Overview 
Most of the tests are automated with very little action from the user necessary.  
When a test panel is open, the configuration (See section 6 of PS-1487 for the different 
configurations) fields are already populated with the default testing conditions (see 
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Appendix D section 9 for default settings of each VI).  If any changes to the 
configuration need to be made they are done at this time, and then the start button is 
pressed.  
The whole test is performed over the course of a few seconds or minutes and a 
report is generated.  Top level test panels, such as the Master Test Panel, contain 
automated tests that combine all the other tests, requiring the user to select only those 
tests which are desired from a list box.  Devices are tested primarily in two states, (Luck, 
2005) board level testing, and (Fox et al., 1996) finished assembly testing.  At the board 
level the Testset can simulate any of the components of the Headset enabling individual 
components to be tested independently of each other.  For instance, the active electrode 
strings or the Uberyoke can be tested independent of the HCU and of each other.  At the 
finished assembly level, the Headset can be tested on a test fixture by injecting biosignals 
into the electrodes simulating a person’s brain, while monitoring the communication of 
the Headset. 
4. Analysis Of The Generated Results  
        Each test produces a set of results, a table or series of values, a graph or chart, and a 
pass/fail reading for the parameters tested.  All raw data was stored in a TDMS file (a 
data file format by National Instruments) which if necessary can be reconstructed later to 
reproduce the test.  The results, graphs and pass fail parameters are printed to a txt file 
which is then converted to a PDF file and stored as a part of the Device History Record 
(DHF). (See a sample report in Appendix D section 13)  
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5. False Positives Vs. False Negatives  
During the design of the tests, and creation of tolerances occasionally a false 
positive or false negative would occur.  While it’s undesirable to have these false results, 
it’s best to error on the side of caution.  Creating tests that will fail by having a false 
negative, or rejection, is safer if necessary and results in a retest or further inspection.  
Having a test that has false positive causes the product to be passed on for further 
assembly or onto sales, which is undesirable. 
6. Noise Test  
The Noise Test shorts the active electrodes inputs to ground, effectively removing 
the electrical influences of anything connected to the electrode, and resulting in any noise 
that is detected being internal to the Electrode string and/or Uberyoke.  Then sampling of 
all channels occurs as the testset “listens” for any noise.  The sampling last for about 25 
seconds, which ensures enough time has passed to detect infrequent popcorn noise  (See 
PS-1487 Section 12) coming from bad switch cap filters as well as ensuring that any slow 
wave (<1 Hz) noise is detected with no less than 2 samples per wave above 0.1 Hz.  After 
the channels have been sampled they are subjected to a variety of processing and testing 
to make sure that the noise that exist on the channels is below a certain threshold and that 
there isn’t any regularity to it. 
7. Cal Tone Test  
The Cal tones are pure tone frequencies of 13.8 Hz and 27.6 Hz that are produced 
in the Uberyoke and travel down the electrode strings and injected into the electrode path 
at the patient’s scalp for the purposes of determining the impedance of the electrodes to 
the scalp.  The reference electrodes emit a low frequency and the other 7 electrodes emit 
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a higher frequency.  The reference signal returns via the regular electrodesThe Caltones’ 
frequencies and amplitudes must be precise in order to properly calculate the impedance 
via a proprietary equation.  This test collects enough samples of data to create an accurate 
Fourier transform, and then the peaks of the two frequencies are detected and subjected to 
pass fail examination to determine if they are acceptable. 
8. Frequency Response  
The Frequency response determines the Headset’s bandwidth.  The Headset has a 
Low Pass Filter (LPF) and a High Pass Filter (HPF).  The passband region must be within 
5% from one Headset to another to ensure accurate results.  The test is run by generating 
a frequency starting at .3 Hz and incrementing the frequency first at 0.1 Hz at a time until 
1Hz is achieved, then after that the increment is 1 Hz up to 50 Hz.  Beyond 50 Hz the 
signal to noise ratio is too low as the 33 Hz LPF has reduced the signal below the 
COGNISION™ Headset’s noise level.  The test is designed to collect no less than 4 
complete cycles per frequency tested to ensure accurate readings.  The drawback is that at 
the frequencies less than 1, the time it takes to capture 4 cycles is longer than the entire 
test above 1Hz.  
9. Common Mode Rejection Ration (CMRR)   
Determines the Headset’s ability to reject signals that are common to the signal 
channels and the ground plane.  Works identically to the Frequency response test 
however the signal is injected into the common channel as well as the signal channels and 
at a greatly amplified value. 
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10. Crosstalk 
            The crosstalk test returns information about how much the signal on one channel 
influences a signal on other channels.  This test was performed by generating an 800 µV 
signal and injecting it into one channel at a time while recording the level of that signal 
on the other channels.  As long as the value on the other channels is below the tolerance 
the system passes.  (See test report for tolerance values Appendix B section 13) 
11. Gain Linearity   
Returns information about the linearity of the amplifiers.  The amplifiers are less 
linear at very low voltages (voltages less than 5 µV) which unfortunately is not much 
smaller than the magnitude of the signal the Headset is trying to capture.  The test starts 
at a voltage of 5µV and increments the voltage by 20µV until it reaches the nonlinear 
region of the DAQ card which is around 700µV.  The linearity is calculated by dividing 
the input by the output for each voltage level.  The test is acceptable as long as the value 
is below .01 for the tested voltages. 
12. Power Consumption Test (Current Draw)  
When the Headset is first put on the test set and powered up, the current draw is 
determined by a series of Kelvin circuits.  These circuits report the current to the analog 
inputs on the DAQ card where they are sampled.  The current draw in this way can be 
determined at any time, however a specific test was designed to determine if the Headset 
has any shorts or opens linked to it’s power distribution, by monitoring for abnormalities 
in its power consumption.  The test starts with the system unpowered, then turns the 
power on and records the value.  Then the impedance switches are shorted at which point 
the power consumption is tested, then the first two steps are done in reverse.  If the 
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current draw is within the acceptable range for each component it is passed (for 
acceptable ranges see Appendix B section 13 and section 9 under current draw). 
13. Time To Complete Testing   
A tradeoff between the tests precision and the length of time it takes to perform 
the test occurs for each of the tests that frequency detection.  The more samples collected, 
the more accurate and precise the test is at detecting the signal.  Most of the test use 
Fourier transforms to move the information from the time domain into the frequency 
domain.  When this happens the number of points of information per frequency is directly 
correlated with the accuracy of the results.  The minimum number of points per 
frequency in the frequency domain for any test performed with the Testset is 2; however 
that is only for very low frequencies, most tests collect enough samples in the pass band 
to ensure a minimum of 4 samples per frequency in the frequency domain. 
14. HCU Function Testing  
The HCU is a complicated electronic device, with multiple states and functions.  
Each of the components and firmware must work to their maximum ability for the system 
to be an effective diagnostic device. Several tests were developed to test each of these 
HCU components: 
15. Field Test  
The field test is a proprietary test built into the HCU firmware that tests some 
internal functionality and is capable of being performed free of the testset.  It can be run 
from the HCU by the user by utilizing a special set of button presses.  The field test is 
able to test the: 
Keypad 
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LCD Screen 
Buttons 
Audio DAC 
Charging Voltage 
Uberyoke voltage draw 
Audio Output 
Audio Attenuator 
Bluetooth 
The field test generates a report that can be recalled, and stored as part of the 
Device History Record. 
16. HCU Console  
The HCU console is the best method for testing the functions of the HCU.  It is a 
comprehensive test suite capable of exercising the functionality of the HCU.  The HCU 
console can perform the Bluetooth discover and pair functions with an HCU; it has the 
following panels that can interact with these different systems (See PS-1492 section 4 for 
tests descriptions). 
i. Firmware loading 
ii. Audio/Audiometry loading 
iii. Audio/Audiometry playback (with an audiometer) 
iv. Impedance Testing 
v. Command Interpretation (Parsing for the different data streams) 
vi. Serial number writer (for both Uberyoke and HCU)  
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vii. Additional testing configurations and detailed information about 
performing each type of test is presented in PS-1487 of appendix B in 
sections 4, 7, 9, and 10 with configurations in section 6.  
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V. RESULTS & DISCUSSION 
Once the Testset and software was completed, Headsets were tested on the 
Testsets and standardized reports were automatically generated at the completion of each 
test.  The automated test suite (the LabVIEW test VIs) took 11.5 minutes to complete all 
tests on a headset.  Two Testsets were used to test one headset for statistical analysis.  
Sample data was utilized from the FZ channel (a point referring to the electrode location 
on the head along the central axis near the frontal lobe) (see FIGURE 13) to perform 
statistical analysis.  This channel and test were chosen because they are the most sensitive 
to failure of any component in the headset.  The wire path is the longest, and it is sampled 
first giving it less settling time than the other channels. 
FIGURE 13 : 10-20 International System Of Electrode Placement  The Channels Used By The CS 
System Are : FZ, CZ, PZ, F4, P4, F3, P3, And Dual Mastoid References 
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A complete test report is presented in PS-1487 section 13 (appendix B), with a 
detailed description of the parameters and interpretations of the different tests presented 
in PS-1487 section 11.  Aberrant tests results of significance are displayed in PS-1487 
section 12.  There are many tools that have been developed to probe the Headset, 
however, there are a few automated test that are capable of producing a text based test 
report with associated image files of the graphs produced.  While the tests are described 
in detail as is the results in the PS-1487, a brief description of each of the test results is 
below.  The tests and results are all channel by channel.  Results are given with a legend 
with reference ranges for acceptable values.  The electrodes are all named by the EEG 
industry standard of the 10:20 system (Niedermeyer & Schomer, 2011). 
 
 
FIGURE 14 : Baseline Noise Time Domain Graph, Shows The Measurement Of Internal Noise 
Occurring In The Uberyoke.  Notice That The Results Signals Change Less Than 5 V Pk-Pk 
A. The Noise and Calibration Tones (Cal tones) test 
This tests the internal noise values, and the Cal Tones.  The noise test (see  
 
FIGURE 14 and Table  for results) collects data without any input into the 
electrodes to determine the internal noise of the system.  The calibration tones are tones 
of a calibrated frequency and amplitude (see  
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FIGURE 15 and Table  for results).  The frequency and amplitude must fall 
within a narrow range.  This test takes duration of 1:46 mm:ss to complete on average. 
TABLE I 
NOISE AND CALTONES TEST RESULTS FOR THE FZ CHANNEL 
    
PASS: 3.051804 µV Noise Vpk-pk: < 5 µV 
PASS: 0.478274 µV Noise V RMS: < 1 µV 
PASS: 13.674458 Hz Low Cal Frequency: 13.50 - 14.50 Hz 
PASS: 32.551223 µV Low Cal Power: 31.5 - 33.5 dB µV 
PASS: 27.349418 Hz High Cal Frequency: 27.00 - 28.00 Hz 
PASS: 32.624808 µV High Cal Power: 31.5 - 33.5 dB µV 
 
The noise test is important for detecting single “pops” in the data sample. Pops 
amongst other common kinds of noises are single peaks of relatively high frequency. 
These are the most common rejection criteria for a headset as the switch cap filter is not 
manufactured to a tight enough tolerance.  As a result even after a “binning” process 
where post purchased testing eliminates all but a few of the unacceptable switch cap 
filters a few are not able to pass the noise test.  Unfortunately in order to catch units that 
have unacceptable switch cap filters that generate pop corn noise, tolerances end up being 
tighter than the variation in the amplifiers during the warm up phase, resulting in the test 
taking extra time.  The Cal tones which are generated by a microcontroller has only failed 
if the commands are not being received by the yoke’s microprocessor or there is an open 
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or short in the circuit.  Solder bridges or poorly soldered vias are the most common cause 
of this failure. Any amount of noise that is underneath the fail level should result in 
uniformity for the data collected from patients by the headset. 
 
 
 
 
 
 
 
 
FIGURE 15 : Cal Tones Power Spectrum (Notice The Peaks At 14 And 28 Hz) 
B. Frequency Response Test Results 
TABLE II  
THE SAMPLE RESULTS GENERATED FROM THE FREQUENCY RESPONSE TEST FOR 
THE FZ CHANNEL. 
FZ / 1 Electrode / Channel 
PASS: data within tolerance Max Deviation: < 0.45 dB @ 0.3-39 Hz 
PASS: data within tolerance Max Deviation: < 2 dB @ 40-50 Hz 
PASS: -2.69 Gain @ 33 Hz: -3.50 < x < -2.50 dB 
PASS: 0.04 Gain @ 10 Hz: -0.50 < x < 0.05 dB 
PASS: -3.17 Gain @ 0.4 Hz: -4.25 < x < -3.25  dB 
PASS: 0.7674 Variance 1-20 Hz : < 1 dB 
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There is an optimal value for each parameter.  This test takes 3:09 mm:ss to 
complete on average.  The max deviation parameter ensures that the gain values for each 
frequency is within a certain range of the “expected output.”  This parameter fails if the 
amplifiers are not set correctly, either a resistor is swapped with the wrong value or the 
amplifiers are not powered correctly was the only cause for this to fail and resulted in 
values with a deviation greater than the 0.45 for the pass band  (See  Table  and  
left for results). 
  
                                                         42 
 
 
FIGURE 16 : (Left) Frequency Response Curve, Notice The 3 Sections: High Pass From 0.3 To 1 Hz, 
Bandpass From 1 To 33 Hz, And Low Pass From 33 To 60 Hz (Right) CMRR Output Image.  All Outputs Are 
Below 90 Db, With The Filters Rejecting The 60 Hz Region Down To 150 Db. 
C. CMRR RESULTS  
TABLE III 
SAMPLE RESULTS GENERATED FROM THE CMRR TEST FOR THE FZ CHANNEL. 
 
The CMRR (See and TABLE III) is the amount of noise rejected when the signal is 
common to all channels.  The CMRR on average test takes 3:29 mm:ss to complete.  The 
lower the signal captured the better the results.  The minimum attenuation is 90 db.  The 
different channels varied from unit to unit by a wide margin however they were all under 
the 90 db mark.  The only failure of this circuit occurred when a polarized capacitor was 
not being checked for its polarity.   
  
FZ / 1 Electrode / Channel 
PASS: -95.41 Min Attenuation: < 90 dB 
PASS: -142.98 CMRR @ 60 HZ: <100 dB 
PASS: -134.87 CMRR @ 50 HZ: < 100 dB 
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FIGURE 17 :  GAIN Linearity Output Image.  Optimal Output Is A Straight Flat Line With X = 1.0 
 
D. GAIN RESULTS 
TABLE IV  
SAMPLE RESULT GENERATED FROM THE GAIN LINEARITY TEST FOR THE FZ CHANNEL. 
 
This gain lineary test takes 3:37 mm:ss on average.  The gain channels gain ratio 
stayed between 1.1 and 0.09 for the duration of the test, showing that the amplifier had a 
linear relationship with the signal input and the amplifier output.  The maximum 
deviation from linearity was 0.025.  This test only fails when the amplifier is non linear, 
usually this is caused by interference since there hasn’t been any faulty amplifiers tested. 
A Headset was repeatedly tested on one Testset and the data was found to support the 
FZ / 1 Electrode / Channel 
PASS: 0.025 Maximum deviation from linearity : < 0.1 
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hypothesis that there was no significant difference in the values collected for the noise 
test on channel FZ with a confidence interval of 95%.  This conclusion was achieved by 
running a 1 sample T test on the headset using Testset 1. 
TABLE V  
DATASET FROM TESTSET 1 
Pk/Pk 
noise (µV) 
RMS 
noise (µV) 
low 
tone (HZ) 
High 
tone (V) 
high 
tone (HZ) 
high 
tone (V) 
3.05180 0.473222 13.6719 32.6013 27.3438 32.5951 
3.32924 0.503080 13.6719 32.5904 27.3438 32.5797 
3.32924 0.471722 13.6719 32.5969 27.3438 32.5850 
3.15180 0.473683 13.6719 32.5920 27.3437 32.5947 
3.32924 0.462220 13.6719 32.5914 27.3438 32.5894 
3.19052 0.479449 13.6719 32.5995 27.3438 32.5940 
3.05180 0.464851 13.6719 32.5924 27.3438 32.5956 
3.32924 0.488411 13.6719 32.5882 27.3438 32.5955 
3.16796 0.480544 13.6719 32.5908 27.3438 32.5935 
3.32924 0.492288 13.6719 32.5987 27.3438 32.6001 
 
TABLE VI 
OUTPUT FROM MINI TAB FOR T TEST ON DATASET 1 
Variable N Mean StDev SE 95% CI 
C1 10 3.2460 0.1491 0.0472 ( 3.1393 3.3527) 
C2 10 0.4862   0.0366 0.0116 ( 0.4600 0.5123) 
C3 10 13.6719   0.0000 0.0000   (13.6719 13.6719) 
C4 10 32.5942   0.0045 0.0014   (32.5909 32.5974) 
C5 10 27.3438   0.0000 0.0000   (27.3437 27.3438) 
C6 10 32.5923   0.0060 0.0019   (32.5880 32.5965) 
 
 
All data fell within the 95% confidence interval.  The Cal tones were shown to be 
read very precisely as they did not differ into the hundredths place for any of the values 
collected.  These values show that when a test is repeatedly performed on a headset, that 
headset’s values all fall within a narrow enough band to not yield a statistically 
significant difference.  The T-test performed on the results show that with at least 95% 
confidence, these values did not different significantly.  In fact for the frequencies of the 
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low and high tone, the values did not differ at all within the precision being captured.  For 
the purposes of collecting ERPs these values show that there is no temporal change in the 
unit that would cause significant differences in the data collected.  Additionally this 
headset was tested on the other testset and a comparison of the two Testsets was made.  
The hypothesis that the Testsets were independent of the data collected was 
supported with a 95% confidence interval. 
TABLE VII 
DATASET FROM TESTSET 2 
Pk/Pk noise (µV) RMS noise (µV) low tone (HZ) low tone (V) high 
tone (HZ) 
high 
tone (V) 
3.34761 0.493075 13.6719 32.5904 27.3438 32.5797 
3.32924 0.485670 13.6719 32.5914 27.3438 32.5894 
3.32824 0.497560 13.6719 32.5987 27.3437 32.6001 
3.35430 0.465432 13.6719 32.5969 27.3438 32.5850 
3.32924 0.475640 13.6719 32.5883 27.3438 32.5956 
3.17564 0.486575 13.6719 32.5920 27.3438 32.5941 
3.08180 0.485750 13.6719 32.5948 27.3438 32.5951 
3.19052 0.485644 13.6719 32.5995 27.3438 32.5939 
3.05180 0.467565 13.6719 32.5924 27.3438 32.5956 
3.16796 0.496456 13.6719 32.5908 27.3438 32.5939 
 
The values from tables 6 and 7 show that when a test is repeatedly performed on a 
headset, that headset’s values all fall within a narrow enough band to not yield a 
statistically significant difference.  The T test performed on the results show that with at 
least 95% confidence, these values did not different significantly.  In fact for the 
frequencies of the low and high tone, the values did not differ at all within the precision 
being captured.  For the purposes of collecting ERPs these values show that there is no 
temporal change in the unit that would cause significant differences in the data collected. 
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TABLE VIII 
PAIRED T TEST FOR DATASET 1 AND 2  FROM TESTSET 1 AND 2 
 
Paired T for FZ1 - FZ2 95% CI for mean difference: (-0.1129, 0.0936) T-Test of 
mean difference = 0 (vs. not = 0): T-Value = -0.21  P-Value = 0.838 
After showing that the Headsets can be repeatedly tested on an individual headset 
without a statistically significant difference between one test and the next it remained to 
show that there was no significant difference between testing on the two different 
Testsets.  The paired T test on the two data sets shows that there is not a statistically 
significant difference between testing on Testset 1 or Testset 2.  Either Testset can be 
used and there will not be a different outcome in the results for a particular headset.  This 
supports the hypothesis that there is no difference between the two Testsets with regards 
to the differences in voltages levels in nano volts. 
Similar analysis was done on the gain values at different frequencies for the 
frequency response test.  The frequency response test was performed at a similar voltage 
of what is expected of the bio signals generated from the brain, 50 µV.   
 
TABLE IX 
FREQUENCY RESPONSE DATA FROM TESTSET 1 
57.13 59.89 62.8177 
57.22 59.94 56.5200 
57.18 59.95 56.5100 
57.22 59.96 56.4500 
57.20 59.89 61.7500 
57.19 59.94 56.5000 
57.18 59.90 56.3800 
57.22 59.94 56.4500 
 N Mean StDev Mean 
FZ1 10 3.2260 0.1174 0.0371 
FZ2 10 3.2356 0.1157 0.0366 
Difference 10 -0.0096 0.1443 0.0456 
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TABLE X 
ONE-SAMPLE T: 0.2-0.9, 1-33, 33-50 FROM TABLE 9 FOR TESTSET 1 
Variable N Mean StDev SE Mean 95% CI 
0.2-0.9    8 57.1937 0.0320 0.0113 (57.1670 57.2205) 
1-33 8 59.9262 0.0283 0.0100 (59.8026 59.9510) 
33-50      8 57.922 2.708 0.957 (55.659 62.186) 
 
The values from Tables 9 and 10 show that when a test is repeatedly performed 
on a headset, that headset’s values all fall within a narrow enough band to not yield a 
statistically significant difference.  The T test performed on the results show that with at 
least 95% confidence, these values did not different significantly.  For the purposes of 
collecting ERPs these values show that there is no temporal change in the unit that would 
cause significant differences in the data collected. 
TABLE XI 
FREQUENCY RESPONSE DATA FROM TESTSET 2 
57.16 59.94 60.8177 
57.24 59.89 57.8900 
57.17 59.95 55.4900 
57.20 59.93 56.4600 
57.19 59.89 61.6500 
57.19 59.94 57.5000 
57.24 59.90 58.5600 
57.22 59.88 57.2700 
 
TABLE XII 
ONE-SAMPLE T: 0.2-0.9, 1-33, 33-50 – FROM TABLE 11 FOR TESTSET 2 
Variable N Mean StDev SE Mean 95% CI 
0.2-0.9 8 57.2013 0.0300 0.0106 (57.1562 57.2263) 
1-33 8 59.9150 0.0278 0.0098 (59.8918 59.9382) 
33-50 8 58.205 2.094 0.740 ( 56.454 59.956) 
Variable N Mean StDev SE Mean 95% CI 
0.2-0.9 8 57.2013 0.0300 0.0106 (57.1562 57.2263) 
1-33 8 59.9150 0.0278 0.0098 (59.8918 59.9382) 
33-50 8 58.205 2.094 0.740 ( 56.454 59.956) 
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The  values from Table 11 and 12 show that when a test is repeatedly performed 
on a headset, that headset’s values all fall within a narrow enough band to not yield a 
statistically significant difference.  The T test performed on the results show that with at 
least 95% confidence, these values did not different significantly.  In fact for the 
frequencies of the low and high tone, the values did not differ at all within the precision 
being captured.  For the purposes of collecting ERPs these values show that there is no 
temporal change in the unit that would cause significant differences in the data collected. 
TABLE XIII 
TWO-SAMPLE T-TEST AND CI: 0.2-0.9, T2 0.2-0.9 
 
Two-sample T for 0.2-0.9 vs t2 0.2-0.9 
Difference = mu (0.2-0.9) - mu (t2 0.2-0.9) 
Estimate for difference:  0.0088 
95% CI for difference:  (-0.0240, 0.0415) 
T-Test of difference = 0 (vs not =): T-Value = 0.58  P-Value = 0.573  DF = 13 
 
This supports the hypothesis that there is no difference between the two Testsets 
with regards to the differences in voltages levels in millivolts, and that the amplified 
values from the headsets and input to the Testsets do not have any statistically significant 
differences. 
 N Mean StDev SE Mean 
0.2-0.9   8 57.2013   0.0300     0.011 
0.2-0.9   8 57.1925   0.0306     0.011 
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The results and statistical analysis from the noise test and the frequency response test 
concur with each other and support the established hypotheses. 
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VI. DISCUSSION 
The benefits of using LabVIEW to control and automate the Testset instead of 
other methods are numerous.  The interfaces are already standardized; buttons and 
displays are drag and drop.  A control panel can be started and finished in an hour.  
According to a study published by National Instruments (Goodin, Squires, & Starr, 1978) 
the company was able to save 60 percent of their initial investment and floor space.  
These compact automated units that are able to perform all the task from a single test 
fixture reducing the afmount of space and time.  Once one of the printed circuit boards 
are mounted on the test fixture, the test can run freely; there is no time lost due to 
removing the printed circuit board and placing it on a second or third test fixture, likewise 
there isn’t any time lost to changing settings in between test.  Ideally, 3 or 4 Testsets 
would be in operation simultaneously, and one technician would operate them in order, 
by setting them up and starting the test before moving to the next one.  Thereby keeping a 
constant cycle of mounting, starting tests and un-mounting the boards. 
Initially the system was designed to use the DAQ card’s analog channels to record 
the playback from the audio components, however, it turned out the dynamic range of the 
analog inputs were not adequate/sufficient to support audio.  Audio usually has a small 
step size in the µV, a 12 bit input with a dynamic range of ±5V results in a step size of 
2.44 volts.  This is 1000 times the necessary step size as the smallest detectable amplitude 
was the equivalent of 60 db on a pair of conventional headphones.   In a redesign of the 
Testboard, an audio DAC could have been used, but a conventional USB audio card was 
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used instead which had inputs that had a suitable dynamic range of 24 bits and ± 3V 
resulting in a step size of around 300 nano volts. 
During testing some electrode strings exhibited some irregular CMRR’s that 
turned out to be correlated with some polarized capacitors being placed on the board 
backwards.  Not all of the capacitors when reversed resulted in the ability to reject the 
electrode with the current equipment.   In a future model an additional circuit will be 
added to test whether these capacitors were soldered on in reverse configuration. 
Currently, the test protocol requires a visual inspection before the boards can be 
tested.  To identify solder bridges, missing chips, and/or other defects.  New inexpensive, 
easy to automate software by National Instruments called MACHINE VISION allows 
rapid image comparisons for visual inspection of equipment such as circuit boards.  Most 
tests in the validation protocol will catch anything wrong with the boards, except poorly 
soldered joints, but there isn’t a way to test the presence of the TVS diodes that protect 
the patients in the instance of some sort of electric discharge. 
Another huge change would be to change the method of signal generation.  The 
testset has a 128 point signal that can be repeated at up to 60 Hz, which can be increased 
at the cost of the number of points.  (2000 Hz is attainable with only around 20 or so data 
points).  A more advanced signal generator would be able to simulate a signwave for 
instance with a high number of points without sacrificing bandwidth.  Additionally, and 
more importantly, a different signal generator could produce multiple frequencies 
simultaneously allowing tests such as CMRR, frequency response, and cross talk to be 
done in seconds instead of minutes, thereby increasing throughput, productivity, and 
reducing the cost of testing. 
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This type of design is remarkable in that it was done by the work of one engineer, 
in the short amount of time. Only recently have computers reached a speed fast enough, 
and the G programming language intuitive enough that this has become a possibility.  
From start of the design to the fabrication of the boards, the entire process was controlled 
and designed on the computer.  The productivity increase in industry as a result of this 
type of ability should lead to cheaper quality control systems, and more of them available 
to small businesses and custom manufacturing. 
Medical devices have a particularly inelastic demand for quality goods, with very 
little margin for faulty equipment.  Risk management is very high on this list because not 
only does the dollar drive the bottom line (cost of lawsuits for defective pacemakers vs. 
the cost to improve the fault detection) but there are ethical and moral considerations that 
decrease obsolesce and failures.  A diagnostic device that serves as early warning for 
disease or a heart pump that literally has a life hanging in the balance will most certainly 
cause pain and suffering if the device fails or behaves aberrantly.   So the development of 
fully automated and inexpensive test systems is a major boon to decreasing the cost of 
medical care.  The advantage is that as more of these systems are employed economies of 
scale will occur, and other industries may be able to take advantage of the testing 
platforms for things that may have had a less robust vetting process in the past. 
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VII. CONCLUSION 
The Headset was developed for more effectively collecting ERP and EEG data for 
the purposes of diagnosing cognitive disorders. The headset is a technologically complex 
machine that requires testing to comply with regulatory rules.  To test and validate this 
medical device two test were developed.    The Testset is capable of testing the entire 
suite of Headset functions.  It meets all specifications, and is automated.  The hypothesis 
of this thesis is supported that a Testset can reliably test a Headset without statistically 
significant variation in the data.  The hypothesis is supported that the two Testsets created 
have a high probability of not yielding different results from one another.  The software is 
able to drive the hardware appropriately and statistical analysis shows that the two 
Testsets in use produce data that is reliable and consistent with each other. 
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VIII. SUGGESTIONS 
The suggestions for this project revolve around the single decision to utilize a 
small third party (non National Instruments) brand of data acquisition card.  Labjack, 
while a very robust DAQ had many issues that would have been resolved by a more 
equipped card, particularly if it wasn’t connected via Ethernet or USB, but rather a direct 
connection to the mother board.  The difference in price for the unit was 10 fold, 5000 vs. 
500.  However, several extra 10k’s where spent as a result of trying to get around the 
issues that came with an in adequate card. 
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Appendix A – Specification Documents 
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Appendix B – Operating Instructions 
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